{"id":"NCT03354429","sponsor":"AstraZeneca","briefTitle":"THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death","officialTitle":"A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared With ASA in the Prevention of Stroke and Death in Patients With Acute Ischaemic Stroke or Transient Ischaemic Attack","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-01-22","primaryCompletion":"2019-12-13","completion":"2019-12-13","firstPosted":"2017-11-28","resultsPosted":"2020-12-22","lastUpdate":"2020-12-22"},"enrollment":11016,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Ischaemic Stroke","Transient Ischaemic Attack"],"interventions":[{"type":"DRUG","name":"Ticagrelor","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"TICAGRELOR","type":"EXPERIMENTAL"},{"label":"TICAGRELOR PLACEBO","type":"PLACEBO_COMPARATOR"}],"summary":"Study to investigate if the study drug ticagrelor and ASA is more effective than Placebo (inactive tablet) and ASA in preventing new stroke events","primaryOutcome":{"measure":"Composite of Subsequent Stroke or Death","timeFrame":"From randomisation (day 1) to visit 3 (day 30-34)","effectByArm":[{"arm":"TICAGRELOR","deltaMin":303,"sd":null},{"arm":"PLACEBO","deltaMin":362,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.015"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":387,"countries":["Argentina","Australia","Belgium","Brazil","Bulgaria","Canada","China","Czechia","France","Germany","Hong Kong","Hungary","India","Italy","Mexico","Peru","Poland","Romania","Russia","Saudi Arabia","Slovakia","South Korea","Spain","Sweden","Taiwan","Thailand","Ukraine","Vietnam"]},"refs":{"pmids":["37637218","34477459","34244703","33940954","33198608","33159526","32668111","30747613","29915123"],"seeAlso":["https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5134C00003&amp;attachmentIdentifier=3c773278-ed11-4f6a-ba36-6d927f39a776&amp;fileName=d5134c00003_SAP_redacted.pdf&amp;versionIdentifier=","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5134C00003&amp;attachmentIdentifier=52098dc2-641a-49a8-8478-d745f5a10a26&amp;fileName=d5134c00003_CSP_redacted.pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":571,"n":5523},"commonTop":[]}}